疟疾
疟疾在非洲和南美多国复燃,与COVID-19相关卫生服务中断有关。部分耐青蒿素的恶性疟原虫株在大湄公河区域根深蒂固并在非洲出现,按蚊继续对杀虫剂产生生理和行为抗性。间日疟消除受不实用且可能有毒的抗复发方案阻碍。寄生虫学诊断和口服或肠外青蒿素联合疗法是患者管理支柱。及时输血、肾脏替代治疗和限制性液体治疗可改善重症疟疾生存。严格使用孕期和婴儿期间歇性预防治疗及季节性化学预防,可能联合WHO于2021和2023年认可的环前期疫苗,可大幅降低疟疾发病率。
要点
- 部分耐青蒿素的恶性疟原虫株已在大湄公河区域根深蒂固并在非洲出现。
- 及时输血、肾脏替代治疗和限制性液体治疗可改善重症疟疾生存。
核心结论
- 疟疾在非洲和南美多国复燃,COVID-19相关卫生服务中断加剧了这一趋势。
- 实现本十年末疟疾减少目标需要改进监测、更好获得有效治疗、更省力的病媒控制、持续药物研发、靶向大规模给药和持续政治承诺。
研究设计与样本
- 综述,基于2021年84个流行国家的估计数据及全球疟疾防控进展。
主要发现
- 部分耐青蒿素的恶性疟原虫株在大湄公河区域根深蒂固,并已在非洲出现。
- 按蚊继续对杀虫剂产生生理和行为抗性。
- 间日疟消除受不实用且可能有毒的抗复发方案阻碍。
- 及时输血、肾脏替代治疗和限制性液体治疗可改善重症疟疾生存。
关键数值与推荐
- 寄生虫学诊断和口服或肠外青蒿素联合疗法是患者管理支柱。
- 严格使用孕期和婴儿期间歇性预防治疗及季节性化学预防,可能联合WHO于2021和2023年认可的环前期疫苗,可大幅降低疟疾发病率。
临床怎么用
- 寄生虫学诊断和口服或肠外青蒿素联合疗法是患者管理支柱。
- 及时输血、肾脏替代治疗和限制性液体治疗可改善重症疟疾生存。
- 严格使用孕期和婴儿期间歇性预防治疗及季节性化学预防,可能联合WHO于2021和2023年认可的环前期疫苗,可大幅降低疟疾发病率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Malaria is resurging in many African and South American countries, exacerbated by COVID-19-related health service disruption. In 2021, there were an estimated 247 million malaria cases and 619 000 deaths in 84 endemic countries. Plasmodium falciparum strains partly resistant to artemisinins are entrenched in the Greater Mekong region and have emerged in Africa, while Anopheles mosquito vectors continue to evolve physiological and behavioural resistance to insecticides. Elimination of Plasmodium vivax malaria is hindered by impractical and potentially toxic antirelapse regimens. Parasitological diagnosis and treatment with oral or parenteral artemisinin-based therapy is the mainstay of patient management. Timely blood transfusion, renal replacement therapy, and restrictive fluid therapy can improve survival in severe malaria. Rigorous use of intermittent preventive treatment in pregnancy and infancy and seasonal chemoprevention, potentially combined with pre-erythrocytic vaccines endorsed by WHO in 2021 and 2023, can substantially reduce malaria morbidity. Improved surveillance, better access to effective treatment, more labour-efficient vector control, continued drug development, targeted mass drug administration, and sustained political commitment are required to achieve targets for malaria reduction by the end of this decade.
引用
- Poespoprodjo JR, Douglas NM, Ansong D, et al. Malaria. Lancet. 2023. PMID: 37924827. doi:10.1016/S0140-6736(23)01249-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。